The Board of Pharmacy announced a rulemaking hearing on September 27 where it is proposing to adopt the following rules. Written comments may be submitted via email to pharmacy.rulemaking@bop.oregon.gov by 4:30 p.m. on September 27.
- Division 007 related to Compliance w/OHA COVID-19 rules
- Divisions 019/041/043/044/139 related to Short-acting Opioid Antagonist
- Division 045 related to USP <795> and USP <797> Standards Adopted by Reference
- Division 115 related to Short-acting Opioid Antagonist
- Divisions 115/125 related to RPH Applicability, Definitions, Counseling; COPT/PT Prohibited Practices
Also in Oregon, the Board of Pharmacy adopted the following rules, effective March 1, 2024, at its August 2023 Board Meeting:
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.